CompletedPhase 3NCT00753064
AScVS and/ or Prazosin for Scorpion Envenomation
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Principal Investigator
- Dr Vivek S Natu, M.S.Vijayshree Hospital, Umroli, Chiplun, Ratnagiri, Maharashtra, India.
- Intervention
- Antiscorpion venom serum(AScVS).(drug)
- Enrollment
- 81 target
- Eligibility
- 12-65 years · All sexes
- Timeline
- 2006 – 2007
Study locations (5)
- Kushte Hospital, Chiplūn, Maharashtra, India
- Natu Hospital, Chiplūn, Maharashtra, India
- Sane Hospital, Chiplūn, Maharashtra, India
- Mangaon cottage hospital, Mangaon., Dist. Raigad., Maharashtra, India
- Vijayshree Hospital,At & Po.Umroli,Tal. Chiplun., Dist. Ratnagiri., Maharashtra, India
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00753064 on ClinicalTrials.gov